Determining the molecular characteristics of one’s disease may influence the therapy employed in the first line as well as subsequent settings.
Scott Huntington, MD, MPH, MSc
Advertisement
Articles by Scott Huntington, MD, MPH, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants FTD to WTX-124 in Advanced Pretreated Cutaneous Melanoma
2
Japan’s MHLW Receives sNDA For T-DXd Combo in Frontline HER2+ Breast Cancer
3
Navigating Dramatic Changes and Using Novel Therapies in CLL Management
4
How Does One Manage Talquetamab’s Unique AE Profile in Multiple Myeloma?
5
